- Home
- SWX vs HUMAW Comparison
SWX vs HUMAW Comparison
Compare SWX & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWX
- HUMAW
- Stock Information
- Founded
- SWX 1931
- HUMAW N/A
- Country
- SWX United States
- HUMAW United States
- Employees
- SWX N/A
- HUMAW 185
- Industry
- SWX Oil & Gas Production
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- SWX Utilities
- HUMAW Health Care
- Exchange
- SWX Nasdaq
- HUMAW Nasdaq
- Market Cap
- SWX 5.4B
- HUMAW N/A
- IPO Year
- SWX N/A
- HUMAW 2020
- Fundamental
- Price
- SWX $69.57
- HUMAW $1.74
- Analyst Decision
- SWX Hold
- HUMAW
- Analyst Count
- SWX 4
- HUMAW 0
- Target Price
- SWX $73.50
- HUMAW N/A
- AVG Volume (30 Days)
- SWX 321.6K
- HUMAW N/A
- Earning Date
- SWX 11-06-2024
- HUMAW N/A
- Dividend Yield
- SWX 3.55%
- HUMAW N/A
- EPS Growth
- SWX N/A
- HUMAW N/A
- EPS
- SWX 2.50
- HUMAW N/A
- Revenue
- SWX $5,209,839,000.00
- HUMAW N/A
- Revenue This Year
- SWX N/A
- HUMAW N/A
- Revenue Next Year
- SWX $1.74
- HUMAW N/A
- P/E Ratio
- SWX $27.86
- HUMAW N/A
- Revenue Growth
- SWX N/A
- HUMAW N/A
- 52 Week Low
- SWX $57.55
- HUMAW N/A
- 52 Week High
- SWX $80.29
- HUMAW N/A
- Technical
- Relative Strength Index (RSI)
- SWX 31.84
- HUMAW N/A
- Support Level
- SWX $67.69
- HUMAW N/A
- Resistance Level
- SWX $79.68
- HUMAW N/A
- Average True Range (ATR)
- SWX 1.49
- HUMAW 0.00
- MACD
- SWX -0.87
- HUMAW 0.00
- Stochastic Oscillator
- SWX 16.95
- HUMAW 0.00
About SWX Southwest Gas Holdings Inc. (DE)
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution and Utility Infrastructure Services units. The first of these encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. The natural gas distribution division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers. The Utility Infrastructure Services segment generates the other half of the company's total revenue from the underground piping contractor services that its subsidiary, Centuri Construction Group, provides.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.